Should all eligible patients with multiple myeloma receive autologous stem-cell transplant as part of initial treatment?

被引：10
|
作者：
Moreau, Philippe [1 ]
Rajkumar, S. Vincent [2 ]
机构：
[1] Univ Hosp Hotel Dieu, F-44093 Nantes, France
[2] Mayo Clin, Div Hematol, Rochester, MN 55905 USA
来源：
LEUKEMIA RESEARCH | 2012年 / 36卷 / 06期
关键词：
HIGH-DOSE THERAPY; STANDARD CHEMOTHERAPY; RANDOMIZED-TRIAL; DEXAMETHASONE; THALIDOMIDE; BORTEZOMIB; CONSOLIDATION; RESCUE;
D O I：
10.1016/j.leukres.2012.02.023
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：677 / 681
页数：5
相关论文
共 50 条
  • [41] Autologous transplant (AT) with peripheral-blood stem-cell rescue for multiple myeloma.: A clinical experience
    Flores, C
    Conte, G
    Fardella, P
    Araos, D
    Alfaro, J
    Aravena, P
    González, N
    Larrondo, M
    REVISTA MEDICA DE CHILE, 2005, 133 (08) : 887 - 893
  • [42] AUTOLOGOUS STEM CELL TRANSPLANT WITH NON CRYOPRESERVED HEMATOPOIETIC STEM CELL IN ALGERIAN PATIENTS WITH MULTIPLE MYELOMA
    Bekadja, A.
    Talhi, S.
    Amani, K.
    Brahimi, M.
    Osmani, S.
    Yafour, N.
    Krim, A.
    Bouhass, R.
    HAEMATOLOGICA, 2016, 101 : 629 - 629
  • [43] Should patients with acute lymphoblastic leukemia receive hematopoietic stem-cell transplant from an unrelated donor?
    Forman, SJ
    NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (01): : 18 - 19
  • [44] Should patients with acute lymphoblastic leukemia receive hematopoietic stem-cell transplant from an unrelated donor?
    Stephen J Forman
    Nature Clinical Practice Oncology, 2005, 2 : 18 - 19
  • [45] Autologous versus allogeneic stem cell transplant for multiple myeloma
    Arora, M
    McGlave, PB
    Burns, LJ
    Miller, JS
    Barker, JN
    Defor, TE
    Weisdorf, DJ
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 71 - 72
  • [46] Multiple Myeloma: Autologous Stem Cell Transplant in an aging population
    King, Justin
    Fiala, Mark
    Goldsmith, Scott
    Stockerl-Goldstein, Keith
    Schroeder, Mark
    Ghobadi, Armin
    Vij, Ravi
    Wildes, Tanya
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E293 - E294
  • [47] Safety Outcomes for Autologous Stem Cell Transplant in Multiple Myeloma
    Gertz, Morie A.
    Buadi, Francis K.
    Hayman, Suzanne R.
    Lacy, Martha Q.
    Dispenzieri, Angela
    Dingli, David
    Gonsalves, Wilson I.
    Kumar, Shaji
    Kapoor, Prashant
    Kourelis, Taxiarchis
    Hogan, William J.
    MAYO CLINIC PROCEEDINGS, 2018, 93 (01) : 56 - 58
  • [48] A CANADIAN COST ANALYSIS COMPARING THE USE OF BORTEZOMIB OR LENALIDOMIDE AS MAINTENANCE THERAPIES IN MULTIPLE MYELOMA PATIENTS ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT
    LeBlanc, R.
    Tay, J.
    Hollmann, S.
    Shustik, J.
    VALUE IN HEALTH, 2014, 17 (03) : A77 - A77
  • [49] Single versus double autologous stem-cell transplantation for multiple myeloma
    Attal, M
    Harousseau, JL
    Facon, T
    Guilhot, F
    Doyen, C
    Fuzibet, JG
    Monconduit, M
    Hulin, C
    Caillot, D
    Bouabdallah, R
    Voillat, L
    Sotto, JJ
    Grosbois, B
    Bataille, R
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (26): : 2495 - 2502
  • [50] Autologous Stem-Cell Transplantation for Multiple Myeloma in the Era of Novel Therapies
    Parrondo, Ricardo D.
    Ailawadhi, Sikander
    Sher, Taimur
    Chanan-Khan, Asher A.
    Roy, Vivek
    JCO ONCOLOGY PRACTICE, 2020, 16 (02) : 56 - +
12345